Cite

HARVARD Citation

    Rolston, K. et al. (2022). In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer. Journal of global antimicrobial resistance. pp. 1-6. [Online]. 
  
Back to record